AU4095899A - Methods and compositions for the detection of human herpesvirus - Google Patents

Methods and compositions for the detection of human herpesvirus

Info

Publication number
AU4095899A
AU4095899A AU40958/99A AU4095899A AU4095899A AU 4095899 A AU4095899 A AU 4095899A AU 40958/99 A AU40958/99 A AU 40958/99A AU 4095899 A AU4095899 A AU 4095899A AU 4095899 A AU4095899 A AU 4095899A
Authority
AU
Australia
Prior art keywords
compositions
detection
methods
human herpesvirus
herpesvirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40958/99A
Inventor
Chou-Pong Pau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU4095899A publication Critical patent/AU4095899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16411—Rhadinovirus, e.g. human herpesvirus 8
    • C12N2710/16422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
AU40958/99A 1998-05-26 1999-05-26 Methods and compositions for the detection of human herpesvirus Abandoned AU4095899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8669598P 1998-05-26 1998-05-26
US60086695 1998-05-26
PCT/US1999/011407 WO1999061909A2 (en) 1998-05-26 1999-05-26 Methods and compositions for the detection of human herpesvirus

Publications (1)

Publication Number Publication Date
AU4095899A true AU4095899A (en) 1999-12-13

Family

ID=22200268

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40958/99A Abandoned AU4095899A (en) 1998-05-26 1999-05-26 Methods and compositions for the detection of human herpesvirus

Country Status (2)

Country Link
AU (1) AU4095899A (en)
WO (1) WO1999061909A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2445309A1 (en) * 2001-04-24 2002-11-07 Otsuka Pharmaceutical Co., Ltd. Crohn's disease antibody-binding peptide and method of examining crohn's disease
WO2009020628A1 (en) * 2007-08-06 2009-02-12 Epiphany Biosciences, Inc. Diagnosis of kaposi's sarcoma-associated herpesvirus (kshv) infection
WO2010093924A1 (en) * 2009-02-12 2010-08-19 Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Serological screening for hhv-8 infection using antigen mixtures

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024057A2 (en) * 1995-12-27 1997-07-10 Yale University Screening tests for lytic cycle antigens and antibodies to kaposi's sarcoma-associated herpesvirus
US6114110A (en) * 1996-01-16 2000-09-05 University Of Michigan Isolation and propagation of a human herpesvirus derived from AIDS-associated Kaposi's sarcoma cells
US7968696B1 (en) * 1996-07-19 2011-06-28 Behring Diagnostics Gmbh Viral interleukin-6
AU4047897A (en) * 1996-07-25 1998-02-20 Trustees Of Columbia University In The City Of New York, The Unique associated kaposi's sarcoma virus sequences and uses thereof
GB9618890D0 (en) * 1996-09-10 1996-10-23 Univ Liverpool An immunogenic determinant
DE59710091D1 (en) * 1997-07-11 2003-06-18 Fleckenstein Bernard Herpes virus (KSHV, HHV-8) encoded by Kaposi's sarcoma and its use in diagnostics and therapy

Also Published As

Publication number Publication date
WO1999061909A3 (en) 2000-03-23
WO1999061909A2 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
AU7812998A (en) Versatile stereotactic device and methods of use
AU6019898A (en) Devices for tissue repair and methods for preparation and use thereof
AU2212299A (en) Compositions and methods for the treatment of tumor
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2389600A (en) Reservoir-and-filter system and method of use
AU2349399A (en) R-lansoprazole compositions and methods
AU5565099A (en) Pharmaceutical compositions and methods for use
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU4215399A (en) Dermatological compositions and methods
AU2781697A (en) Methods and apparatus for the detection of dental caries
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU2001249444A1 (en) Methods and compositions for the simultaneous detection of multiple analytes
GB9816761D0 (en) Herpesvirus preparations and their uses
AU5427398A (en) Cytoperfusion of tissue specimens
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU3118297A (en) Sok-1 and methods of use
EP1139981A4 (en) Compositions and methods of using the same
AU6412599A (en) Oxybutynin formulations and methods of use
AU1522400A (en) Substituted pyrimidine compositions and methods of use
AU4095899A (en) Methods and compositions for the detection of human herpesvirus
AU2115197A (en) Compositions and methods useful in the detection and/or treatment of cancerous conditions
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
AU2880699A (en) Pharmaceutical compositions and methods for use
AU2672597A (en) Probes for the detection of human papillomavirus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase